Genital tract and plasma human immunodeficiency virus viral load throughout the menstrual cycle in women who are infected with ovulatory human immunodeficiency virus

American Journal of Obstetrics and Gynecology

Volumn 188, Issue 1, 2003, Pages 122-128

  Money, Deborah M ^a   Arikan, Yasmin Y ^b   Remple, Valencia ^b   Sherlock, Chris ^b   Craib, Kevin ^b   Birch, Patricia ^b   Burdge, David R ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b NONE

Author keywords

Genital; Human immunodeficiency virus; Plasma; Viral load; Women

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; FEMALE; FEMALE GENITAL SYSTEM; FOLLICULAR PHASE; HELPER CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LUTEAL PHASE; LYMPHOCYTE COUNT; MENSTRUAL CYCLE; PLASMA; PRIORITY JOURNAL; PROSPECTIVE STUDY; UTERINE CERVIX; VAGINA; VIRUS LOAD;

EID: 0037249860     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1067/mob.2003.65     Document Type: Article

References (27)

1. Hart CE, Lennox JL, Pratt-Palmore M, Wright TC, Schinazi RF, Evans-Strickfaden T, et al. Correlation of human immunodeficiency virus type 1 RNA levels in blood and the female genital tract. J Infect Dis 1999;179:871-82.
2. Cu Uvin S, Caliendo AM. Cervicovaginal human immunodeficiency virus secretion and plasma viral load in human immunodeficiency virus-seropositive women. Obstet Gynecol 1997;90: 739-43.
3. Iverson AKN, Larsen AR, Jensen T, Fugger L, Balslev U, Wahl S, et al. Distinct determinants of human immunodeficiency virus type 1 RNA and DNA loads in vaginal and cervical secretions. J Infect Dis 1998;177:1214-20.
4. Goulston C, McFarland W, Katzenstein D. Human immunodeficiency virus type 1 RNA shedding in the female genital tract. J Infect Dis 1998;177:1100-3.
5. Shaheen F, Sison AV, McIntosh L, Mukhtar M, Pomerantz RJ. Analysis of HIV-1 in the cervicovaginal secretions and blood of pregnant and nonpregnant women. J Human Virol 1999;2: 154-66.
6. Rasheed S, Li Z, Zu D, Kovacs A. Presence of cell-free human immunodeficiency virus in cervcovaginal secretions is independent of viral load in the blood of human immunodeficiency virus-infected women. Am J Obstet Gynecol 1996;175:122-30.
7. John GC, Nduati RW, Mbori-Ngacha D Overbaugh J, Welch M, Richardson BA, et al. Genital shedding of human immunodeficiency virus type 1 DNA during pregnancy: association with immunosuppression, abnormal cervical or vaginal discharge and severe vitamin A deficiency. J Infect Dis 1997;175:57-62.
8. Reichelderfer PS, Coombs RW, Wright DJ, Cohn J, Burns DN, Cu-Uvin S, et al. Effect of menstrual cycle on HIV-1 levels in the peripheral blood and genital tract: WHS 001 study team. AIDS 2000;14:2101-7.
9. Wright TC, Subbareo S, Ellerbrock TV, Lennox JL, Evans-Strickfaden T, Smith DG, et al. Human immunodeficiency virus 1 expression in the female genital tract in association with cervical inflammation and ulceration. Am J Obstet Gynecol 2001; 184:279-85.
10. Ghys PD, Fransen K, Diallo MO, Ettiegne-Traore V, Coulibaly IM, Yeboue KM, et al. The associations between cervicovaginal HIV shedding, sexually transmitted diseases and immunosuppression in female sex workers in Abidjan, Cote d'Ivoire. AIDS 1997;11:F85-93.
11. Cu-Uvin S, Hogan JW, Caliendo AM, Harwell J, Mayer KH, Carpenter CCJ, for the HIV Epidemiology Research Study. Association between bacterial vaginosis and expression of human immunodeficiency virus type 1 RNA in the female genital tract. Clin Infect Dis 2001;33:894-6.
12. McClelland RS, Wang CC, Mandaliya K, Overbaugh J, Reiner MT, Panteleef DD, et al. Treatment of cervicitis is associated with decreased cervical shedding of HIV-1. AIDS 2001;15:105-10.
13. Wang CC, McClelland RS, Reilly M, Overbaugh J, Emery SR, Mandaliya K, et al. The effect of treatment of vaginal infections on shedding of human immunodeficiency virus type 1. J Infect Dis 2001;183:1017-22.
14. Farzadegan H, Hoover DR, Astemborski J, Lyles CM, Margolick JB, Margham RB, et al. Sex differences in HIV-1 viral load and progression to AIDS. Lancet 1998;352:1510-4.
15. Sterling TR, Vlahov D, Astemborski J, Hoover DR, Margolick JB, Quinn TC, et al. Initial plasma HIV-1 RNA levels and progression to AIDS in women and men. N Engl J Med 2001;344:720-5.
16. Greenblatt RM, Ameli N, Grant RM, Bacchetti P, Taylor RN. Impact of the ovulatory cycle on virologic and immunologic markers in HIV infected women. J Infect Dis 2000;181:82-90.
17. Clemetson DBA, Moss GB, Willerford DM, Hensel M, Emonyi W, Holmes KK, et al. Detection of HIV DNA in cervical and vaginal secretions: prevalence and correlates among women in Nairobi, Kenya. JAMA 1993;269:2860-4.
18. Vogt MW, Witt DJ, Craven DE, Byington R, Crawford DF, Hutchinson MS, et al. Isolation patterns of the human immunodeficiency virus from cervical secretions during the menstrual cycle of women at risk for the acquired immunodeficiency syndrome. Ann Intern Med 1987;106:380-2.
19. Mostad SB, Jackson S, Overbaugh J, Reilly M, Chohan B, Mandaliya K, et al. Cervical and vaginal shedding of human immunodeficiency virus type 1-infected cells throughout the menstrual cycle. J Infect Dis 1998:178:983-91.
20. Chakraborty H, Sen PK, Helms RW, Vernazza PL, Fiscus SA, Eron JJ, et al. Viral burden in genital secretions determines male-to-female sexual transmission of HIV-1: a probabilistic empiric model. AIDS 2001;15:621-7.
21. Dickover RE, Garraty EM, Herman SA, Sim, M-S, Plaeger S, Boyer PJ, et al. Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission: effect of maternal zidovudine treatment on viral load. JAMA 1996; 275:599-605.
22. Mofenson LM, Lambert JS, Stiehm ER, Bethel J, Meyer WA, Whitehouse J, et al. Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. N Engl J Med 1999;341:385-93.
23. Sherlock CH, Money D, Craib KJP, Merrick L, Arikan Y, Remple V, et al. Are measurements of genital HIV-1 viral load in women reproducible? [abstract] Proceedings of the 8th Conference on Retroviruses and Opportunistic Infections; 2001 February 4-8; Chicago, Ill. Chicago: The Conference; 2001.
24. Kutteh WH, Moldoveanu Z, Mestecky J. Mucosal immunity in the female reproductive tract: correlation of immunoglobins, cytokines, and reproductive hormones in human cervical mucus around the time of ovulation. AIDS Res Hum Retroviruses 1998;14(1 Suppl):S51-5.
25. Al-Harthi L, Kovacs A, Coombs RW, Reichelderfer PS, Wright DJ, Cohen MH, et al. A menstrual cycle pattern for cytokine levels exists in HIV-positive women: implication for HIV vaginal and plasma shedding. AIDS 2001;15:1535-43.
26. Collis T, Celum C, Whittington W, Lucchetti A, Sanchez J, Lockhart D, et al. Compartmentalization and variability in HIV-1 shedding in blood, semen, rectum and pharynx [abstract]. Proceedings of the 8th Conference on Retroviruses and Opportunistic Infections; 2001 February 4-8, 2001; Chicago, Ill. Chicago: The Conference; 2001.
27. Coombs RW, Wright DJ, Reichelderfer PS, Burns DN, Cohn J, Cu-Uvin S, et al. Variation of human immunodeficiency virus type 1 viral RNA levels in the female genital tract: implications for applying measurements to individual women. J Infect Dis 2001;184:1187-91.